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Abstract  
Introduction: Large for gestational age (LGA) infants are associated with increased risk of neonatal 
morbidity and mortality, however most of them will not have adverse outcomes. Our aim was to 
identify antenatal clinical factors associated with neonatal morbidity in LGA infants. Material and 
methods: Nulliparous women from the Screening for Pregnancy Endpoints (SCOPE) study were 
included. We compared maternal and fetal factors between LGA infants (birthweight >90th 
customized centile) with and without neonatal morbidity, defined as admission to neonatal intensive 
care unit or severe neonatal morbidity. Factors were selected based on a-priori hypotheses of 
association and included maternal demography, anthropometric measures and self-reported 
physical activity (15 and 20 weeks), fetal biometry (20 weeks), and clinical information. Multivariable 
logistic regression was used to identify risk factors. Stratified analyses were performed by maternal 
obesity and physical activity. Results: Amongst term pregnancies, prevalence of LGA infants was 
9.3% (491/5,255), with 11.8% (58/491) prevalence of neonatal morbidity.  Random glucose at 20 
weeks (OR 1.52; 95% CI1.17 to 1.97, per 1mmol/L increase) and no regular physical activity at 20 
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weeks (3.93; 1.75 to 8.83) were associated with increased risk of neonatal morbidity after 
adjustment for birthweight, gestational age at delivery and gestational diabetes. The increased risk 
associated with higher glucose levels was not evident in women with regular physical activity or 
without obesity. Conclusions: Regular physical activity in mid-pregnancy is associated with lower risk 
for neonatal morbidity in LGA infants and seems to offer protection against the increased risk 
associated with higher maternal glucose levels. 
 
Key words 
Large for gestational age, macrosomia, risk factors, adverse outcome, neonatal morbidity. 
 
Abbreviations 
AC  abdominal circumference 
BMI  body mass index 
FL  femur length 
GDM  gestational diabetes mellitus 
HC  head circumference 
LGA  large for gestational age 
NICU  neonatal intensive care unit 
SGA  small for gestational age 
SNM  severe neonatal morbidity 
 
Key message 
Factors associated with neonatal morbidity in large for gestational age infants are present as early as 
20 weeks. Regular physical activity is a modifiable factor related to reduced risk and seems to 
protect against the deleterious effect of higher maternal glucose. 
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Introduction  
 
The population prevalence of risk factors associated with delivery of a large for gestational 
age (LGA) infant, particularly maternal obesity, is increasing (1). LGA, most often defined as a 
birthweight above the 90th centile, is associated with significant maternal and neonatal morbidity 
and mortality (2, 3); LGA increases the risk of neonatal Apgar score below seven at five minutes, 
shoulder dystocia and neonatal intensive care unit (NICU) admission (4, 5) and maternal risks include 
higher cesarean section rates, postpartum hemorrhage and 3rd and 4th degree tear (4, 5). 
 
The majority of LGA infants at term, although at higher risk, will not experience any short-
term adverse perinatal outcomes. The incidence of neonatal morbidity, as assessed through NICU 
admission, is approximately 5-12% (4, 6). Improved antenatal detection of LGA infants and 
appropriate management of delivery in suspected LGA infants has the potential to prevent delivery 
related neonatal morbidity (7), but interventions in pregnancy aimed to prevent LGA in high-risk 
groups, have, to date, not reduced either incidence or related morbidity (8, 9). We recently reported 
a prediction model in early pregnancy for LGA infants with modest performance at 20 weeks’ 
gestation but with the potential to inform which women might benefit from a third trimester 
ultrasound (10).  We hypothesized that improved identification of maternal factors linked to 
neonatal morbidities in LGA infants will better define a selected group of mothers in whom early 
interventions are more likely to be effective in prevention of LGA related morbidities. In addition, 
the identification of antenatal risk factors would allow for better risk stratification so that clinician 
can better anticipate adverse neonatal outcomes in LGA infants. 
 
Our aim was to determine the incidence of severe neonatal morbidity (SNM) and NICU 
admission in LGA infants by customized centiles at term and to identify antenatal clinical factors 
associated with these adverse outcomes amongst LGA infants. 
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Material and methods 
Participants were healthy nulliparous women recruited to the SCOPE (Screening for 
Pregnancy Endpoints) study in Auckland, New Zealand; Adelaide, Australia; London, Leeds and 
Manchester, UK; and Cork, Ireland. This is a multicenter cohort, the primary aim of which was to 
develop screening tests for prediction of preeclampsia, preterm birth and small for gestational age 
babies (SGA) (11). Eligible nulliparous women with singleton pregnancies were recruited between 
14-16 weeks’ gestation between 2004 and 2011 (consecutive recruitment of women). Women were 
excluded if they had chronic hypertension requiring antihypertensive drugs, pre-gestational 
diabetes, renal disease, systemic lupus erythematosus, antiphospholipid syndrome, sickle cell 
disease, HIV, previous cervical knife cone biopsy, three or more previous miscarriages or 
terminations of pregnancy, current ruptured of membranes, known major fetal anomaly or 
abnormal karyotype, and those who received interventions that may modify pregnancy outcomes. 
 
At study entry, extensive participant assessment recorded demographic characteristics, 
clinical and behavioral information, physical and laboratorial examinations, and an ultrasound scan. 
At 19-21 weeks, women returned for clinical assessment and an anatomy ultrasound was also 
performed. Blood samples were taken at both visits. Women were followed until 30 days 
postpartum and data was recorded for any event during pregnancy, at delivery or during the 
neonatal period. 
 
For the present study, only women whose infants were born at term (delivered at or after 37 
completed weeks) were included. Additional exclusion criteria for this analysis were infants SGA or 
appropriate for gestational age infants according to customized centiles (≤90th percentile). 
Birthweight customized centiles were calculated adjusting for maternal height and weight, ethnicity, 
parity, fetal sex, and gestational age (12).  
 
The primary outcome was a composite of neonatal morbidity, which included SNM or NICU 
admission. SNM was defined as stillbirth, neonatal death or other severe neonatal morbidities, 
which included one or more of the following: grade II or III hypoxic ischemic encephalopathy, Apgar 
score of less than four at five minutes, arterial cord pH < 7.0 and/or base excess less than -15, 
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neonatal seizures, neonatal ventilation for longer than 24 hours or admission to the NICU for longer 
than four days. 
 
Factors were selected for analysis based on a-priori hypotheses of association and were 
composed of maternal age and birthweight, ethnicity, educational level, job situation, family history 
of diabetes or gestational diabetes mellitus (GDM), maternal anthropometry (weight, height and 
body mass index (BMI)), systolic blood pressure, random glucose (15 and 20 weeks), weight change 
between 15 and 20 weeks, physical activity during pregnancy (15 and 20 weeks), fetal biometry at 20 
weeks scan (head circumference (HC), abdominal circumference (AC), femur length (FL) and head 
circumference to abdominal circumference (HC/AC) ratio), GDM and hypertensive disorders in 
current pregnancy.  
 
Ethnicity was grouped as European, Asian, Maori or other. Educational level was assessed by 
total number of schooling years and job situation was divided in the following categories: full time 
work, part time work or other. Physical activity was assessed using a questionnaire developed 
specifically for this study and was categorized into three levels of intensity: vigorous (physical 
activities that made the woman breathe harder), moderate (physical activities that did not make the 
women breathe harder), light (walking for recreation of exercise). Participants were categorized by 
the highest intensity level of physical activity they regularly performed (at least once a week). No 
regular physical activity was defined as absence of any kind of regular (at least once a week) self-
reported physical activity (vigorous moderate and light). Women were defined as having GDM 
according to local policies. Women without a 75g Oral Glucose Tolerance Test (OGTT) were 
considered as unknown GDM status; these were women without risk factors according to local 
policy. Preeclampsia was defined as systolic blood pressure ≥140 mmHg and/or diastolic blood 
pressure ≥90 mmHg on at least two occasions four hours apart after 20 weeks of gestation but 
before the onset of labor, or postpartum, with either proteinuria (24 hour urine protein ≥300 mg or 
spot urine protein to creatinine ratio ≥ 30 mg/mmol or urine dipstick protein ≥ 2+) or any multi-
system complication of preeclampsia. 
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Statistical analyses 
All women with known outcomes were included in the analysis. Missing data was minimal 
(<3%) for the exposures; except for maternal birthweight (n=32; 6.5%). Missing data were imputed 
for analyses using expected maximization, or for variables unrelated to other data points that had 
<1% missing data, single imputation was performed using the median (continuous variables) or 
mode (binary/categorical variables) as previously described.(6) Factors were summarized as mean 
and standard deviation (SD), median and interquartile range (IQR) or by frequency (proportion), as 
appropriate. Comparison between groups was by t-test, Mann-Whitney test or chi square/exact test, 
as appropriate. Factors with p<0.05 were combined in a multivariable model. Logistic regression was 
used to identify risk factors for neonatal morbidity. A pre-defined adjustment for GDM status, 
birthweight, and gestation at delivery was performed. Risk factors were identified by a significant 
association in a multivariable model (p<0.05). Potential use of factors for risk stratification was 
assessed based on antenatal risk factors identified. In addition, we explored obesity as a factor for 
risk stratification due to known association with adverse outcomes.(13) Formal interaction test 
between variables assessed for risk stratification was performed using likelihood ratio tests. All 
analyses were performed in Stata software, version 14.1 (StataCorp LP, College Station, Texas). This 
study has been reported in line with STROBE recommendations (14).  
 
 Ethical approval  
Ethical approval was obtained in each participant local ethics committees (New Zealand 
AKX/02/00/364, Australia REC 1712/5/2008, London, Leeds and Manchester 06/MRE01/98, and Cork 
ECM5 (10) 05/02/08) and all participants provided written informed consent. 
 
Results 
 
Amongst the 5628 women recruited in SCOPE, data from those with preterm birth (n=351), 
miscarriage (n=18) and with missing information on birthweight centile (n=4) were excluded. In term 
pregnancies, 80.4% (4225/5255) were appropriate for gestational age infants and 10.3% (538/5255) 
were SGA pregnancies at term (Figure 1). The present analysis was restricted to the remaining 9.3% 
(491/5255) women with LGA at term. The prevalence of LGA related morbidity in this group was 
11.8% (58/491) using a composite fetal outcome of either SNM or NICU admission. This comprised 
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4.5% (22/491) SNM and 11.0% (54/491) NICU admission. Four SNM infants were not admitted to 
NICU (3 stillbirths at term and one infant (Apgar 10 at 5 minutes) with a low cord blood pH and a 
fractured clavicle).   
 
Comparisons between LGA infants with and without morbidity are described in Table 1. 
There was a higher prevalence of maternal obesity in the neonatal morbidity group (24.1% vs. 
11.8%, p=0.01). Other demographic and clinical characteristics in early pregnancy (15 weeks) were 
not different between groups. At 20 weeks, the mean random glucose concentration was higher in 
women whose LGA infant had morbidity after birth compared to women with LGA infants without 
morbidity (6.1 ±1.1 mmol/L vs. 5.5 ±1.0 mmol/L, p<0.001). Also, mothers of infants with morbidity 
were more likely not to routinely engage in physical activity at 20 weeks (20.7% vs. 5.8%, p<0.001). 
In women who reported physical activity during mid-pregnancy, the intensity of self-reported 
physical activity was not different between those with infant morbidity and those without. Fetal 
biometry measures at anatomy scan were not different but the HC/AC ratio was lower in babies that 
later developed morbidity (p=0.03). 
 
Maternal pregnancy complications were similar in morbidity and no morbidity groups, with 
no significant difference in preeclampsia, gestational hypertension and mode of delivery (Table 2).  
However, induction of labor was more frequent (37.9% vs. 22.6%, p=0.006) and birthweight higher 
(4300 ±440 g vs. 4183 ±347 g, p=0.02) in LGA infants with morbidity.  
 
In multivariable analysis, random glucose at 20 weeks (adjusted odds ratio 1.52; 95% 
confidence interval 1.17 to 1.97, per 1 mmol/L increase) and no regular physical activity at 20 weeks 
(3.93; 1.75 to 8.83) were associated with increased risk of neonatal morbidity after adjustment for 
birthweight, gestation at delivery and GDM status (Table 3).    
 
Maternal risk factors were used to stratify the risk at mid pregnancy of morbidity in LGA 
infants. Random glucose was categorized into three groups using approximates of the interquartile 
range (<25th, 25th–75th, >75th) and plotted according to physical activity status (Figure 2a). Women 
not undertaking regular physical activity had an increased risk of morbidity when random glucose 
was between 5.0 and 6.0 mmol/l or higher than 6.0 mmol/l (p<0.001 and p<0.001, respectively). 
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However, in women undertaking regular physical activity, there was no association between glucose 
category and risk of morbidity. Stratification according to obesity was also assessed (Figure 2b and 
2c). In obese women, random glucose > 6.0 mmol/l was associated with increased risk of neonatal 
morbidity (p=0.03), but this was not observed in women without obesity. No regular physical activity 
was associated with neonatal morbidity in women with or without obesity (p=0.001 and p=0.04, 
respectively) and the combination of no regular physical activity and being obese identified women 
with highest rate of neonatal morbidity. Interaction tests between glucose and physical activity, 
glucose and obesity, and physical activity and obesity showed no evidence for interaction (p=0.19, 
p=0.16, and p=0.18, respectively) although limitations of sample size may have compromised 
statistical power.  
 
Discussion 
Delivery of a LGA baby is associated with increased risk of adverse perinatal outcomes (4-6, 
15). In this analysis of a large low risk primiparous cohort, we have identified differences in maternal 
characteristics during pregnancy between LGA infants with and without neonatal morbidity as early 
as mid-pregnancy. Plasma glucose concentration and no regular self-reported physical activity in 
mid-pregnancy were independently associated with increased risk of SNM or NICU admission. These 
findings may provide insight into metabolic pathways involved in LGA and related morbidity. 
Amongst pregnancies with LGA infants, induction of labor and birthweight were also associated with 
adverse outcome, which reflects the challenge in managing delivery of these overgrown infants.  
 
The metabolic pathways leading to LGA are incompletely understood (16). Maternal GDM, 
obesity and excessive gestational weight gain are strong risk factors; for example, LGA increases 
from 5.7% in normal BMI women to 8.6-13.9% when BMI is >30 kg/m2 (17).  We found that the 
prevalence of maternal obesity is also different between LGA infants with and without morbidity but 
that this association was attenuated following adjustment for other factors including maternal 
random glucose at 20 weeks. In agreement with others we found a pivotal role for maternal 
dysglycemia in the pathway between maternal metabolic dysfunction and LGA-related neonatal 
morbidity, with an approximately 1.5-fold increase in the odds of neonatal morbidity in LGA infants 
for each unit increase in random glucose levels at 20 weeks. This association is not specific to fetal 
overgrowth; the HAPO study described higher glycemic levels (in a pre-diabetic range) during the 
OGTT to be associated with adverse perinatal outcomes, such as shoulder dystocia or birth injury, 
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hyperbilirubinemia, NICU admission as well as giving birth to an LGA infant (18). These data reinforce 
the recommendations for adoption of healthy lifestyle behaviors in pregnancy which are likely to 
improve glucose homeostasis. This advice seems to be applicable to all women since our findings are 
derived from a low risk population.  
 
Another potential modifiable factor identified was physical activity during mid-pregnancy. 
Physical activity is safe during pregnancy and the American College of Obstetricians and 
Gynecologists guidelines recommends 30 minutes of moderate physical activity in most, if not all 
days of the week (19). The UK Chief Medical Officers have reinforced this by recently recommending 
150 minutes of moderate physical activity per week for pregnant women (20). Physical activity has 
been associated with improved insulin sensitivity in both non-pregnant (21) and pregnant women 
(22). Insulin sensitivity during pregnancy seems to be associated with favorable fat distribution in the 
offspring and physical activity is likely to mediate this relation (23). Furthermore, physical activity 
during pregnancy improves gestational weight gain control, reduces symptoms of depression, and 
prevents urinary incontinence and low back pain whilst not influencing birthweight (24). Watson and 
McDonald, assessing physical activity during pregnancy in 197 unselected women, described that a 
lower level of maternal physical activity was associated with a greater probability of admission to 
NICU and premature delivery (25). Focusing on LGA infants, we observed a three-fold increase in the 
chance of neonatal morbidity in women who did not take physical activity regularly during mid-
pregnancy. As this was unaffected after adjustment for the maternal glucose concentration, this 
implies that physical activity has benefits other than through improved glucose homeostasis. This 
finding adds support to the recommendation of physical activity in pregnancy.   
 
These risk factors associated with LGA-related morbidity may be useful in stratification of a 
high-risk group for targeted intervention or increased surveillance. We recently reported early 
pregnancy predictors of LGA including maternal birthweight, random glucose at 14-16 weeks, weight 
gain between (between 14-16 and 19-21 weeks) and ultrasound parameters at the anatomy scan 
(10). Random glucose was also associated with neonatal morbidity in the present study, whereas the 
other factors were not. LGA infants whose mother had a random glucose above 5.0 mmol/L and did 
not undertake regular physical activity at 20 weeks had a rate of admission to NICU or SNM of above 
30% (Figure 2a). The combination of a random glucose above 6.0 mmol/L or no regular physical 
activity at 20 weeks with an early pregnancy BMI above 30 kg/m2 were also associated with a rate of 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
neonatal morbidity above 30%. This is much higher than the expected 5.4-11.7% rate of admission to 
NICU for LGA infants (4, 6).  
 
Most lifestyle interventions involving physical activity during pregnancy have been shown to 
reduce gestational weight gain during pregnancy but have not reduced the risk of GDM, LGA or 
neonatal morbidity; the latter is often a secondary outcome in these trials (26, 27). We recognize 
that the causes of neonatal morbidity relates to fetal growth (SGA or LGA) (28). Our findings suggest 
that lifestyle interventions based on physical activity are more likely to improve neonatal outcomes 
in LGA infants either born to obese women or women with high glucose concentration in mid 
pregnancy. Our findings of associations from the present observational study should be tested for 
evidence of causation through randomized controlled trials. Future trials should consider these 
higher risk subgroups and focus on more clinically relevant outcomes such as LGA related morbidity.  
The ability to design a targeted intervention based on the identified risk factors is limited by the 
definition of LGA used, which is only available after birth. Our findings should be validated by 
ultrasound detection of LGA before planning any intervention. Nonetheless, the risk factors 
identified here may assist neonatologists in deciding the level of post-natal surveillance for LGA 
infants. 
 
The strength of this study includes a large prospective cohort and a very low loss of follow 
up. Although neonatal morbidity at term was not restricted to LGA infants, it is likely that the causes 
varied according to the growth status. Therefore, our approach of assessing LGA infants separately 
provides a clearer insight on the mechanisms related to morbidity in this group. As SCOPE’s primary 
aim was prediction of preeclampsia, SGA and preterm birth, data on shoulder dystocia and brachial 
plexus injury was not routinely collected. Systematic recording of these outcomes might reveal a 
mechanical pathway to neonatal morbidity related to birth trauma (29). Assessment of physical 
activity is widely discussed in the literature and there is considerable variation on the accuracy of 
self-report compared to direct measurement both in adults (30, 31) and in pregnant women (32, 33). 
Our physical activity questionnaire was developed by a combination of existing resources at the start 
of the study and has not been previously validated which is a limitation of our study; our findings 
need to be replicated using existing validated questionnaires however the strength of association 
observed with no regular physical activity has biological possibility and will likely be replicated. The 
absence of indication for NICU admission also limited our analysis. Hypoglycemia, possibly followed 
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by hyperbilirubinemia, was likely to be the major reason on the basis of the sample characteristics 
and risk factors identified. We observed a higher rate of induction of labor in the LGA group with 
morbidity but, in the absence of data for reasons for induction, interpretation is limited. The 
differing protocols for GDM screening between centers was also a limitation but amongst those 
untested for GDM, the LGA rates and LGA related morbidities were lower, indicating a lower risk 
status.  
 
In summary, a combination of risk factors identified a group of LGA with considerable 
prevalence of neonatal morbidity. Regular physical activity in mid-pregnancy is associated with lower 
risk for neonatal morbidity in LGA infants and seems to offer protection against the increased risk 
associated with higher maternal glucose levels. Our findings add to the evidence advocating physical 
activity throughout pregnancy. 
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Figure legends 
 
Figure 1. Study population. 
 
Figure 2. Rate of neonatal morbidity stratified by random glucose and physical activity at 19-21 
weeks and maternal obesity.
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Table 1. Characteristics of pregnancies of large for gestational age infants with and without neonatal 
morbidity. 
  LGA no morbidity LGA and morbidity 
 
 
(n=433; 88%) (n=58; 12%) 
 
 
Mean ±SD or n (%) Mean ±SD or n (%) p value 
Age 29.1 ±5.4 28.5 ±5.7 0.40 
Maternal birthweight 3420 ±590 3472 ±571 0.52 
Ethnicity 
   
    European 375 (86.6) 55 (94.8) 
 
    Asian 34 (7.9) 1 (1.7) 0.32 
    Maori 12 (2.8) 1 (1.7) 
 
    Other 12 (2.8) 1 (1.7) 
 
FH Diabetes or GDM 72 (16.6) 10 (17.2) 0.91 
Educational level (<12 years) 151 (34.9) 20 (34.5) 0.95 
Full- or part-time job 378 (87.3) 50 (86.2) 0.82 
BMI Category 
   
   Underweight 5 (1.2) 1 (1.7) 
 
   Normal 248 (57.3) 32 (55.2) 0.04 
   Overweight 129 (29.8) 11 (19.0) 
 
   Obese 51 (11.8) 14 (24.1) 0.01
a
 
Height 165 ±7 166 ±7 0.09 
Weight 
b
 65 (59-74) 69 (58-86) 0.35 
Systolic BP 106 ±10 105 ±12 0.68 
Rand. Glucose at 15w 5.4 ±1.0 5.6 ±1.0 0.12 
No regular physical activity at 15w 40 (9.2) 8 (13.8) 0.27 
Physical activity intensity 
   
  Light 66 (16.8) 13 (26.0) 
 
  Moderate 193 (49.1) 22 (44.0) 0.28 
  Vigorous 134 (34.1) 15 (30.0) 
 
Wgt change 15-20w (kg/week) 0.6 ±0.4 0.7 ±0.5 0.04 
Rand. glucose at 20w 5.5 ±1.0 6.1 ±1.1 <0.001 
No regular physical activity at 20w 25 (5.8) 12 (20.7) <0.001 
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Physical activity intensity 
   
  Light 63 (15.4) 6 (13) 
 
  Moderate 195 (47.8) 22 (47.8) 0.90 
  Vigorous 150 (36.8) 18 (39.1) 
 
US HC z-score 0.5 ±1.0 0.2 ±1.2 0.09 
US AC z-score 0.5 ±1.2 0.6 ±1.1 0.52 
US FL z-score 0.2 ±1.1 0.2 ±0.8 0.90 
US HC/AC ratio 1.14 ±0.05 1.12 ±0.05 0.03 
Abbreviations: AC – abdominal circumference, BMI – body mass index, BP – blood pressure, FH – family 
history, FL – femur length, GDM – gestational diabetes mellitus, HC – head circumference, LGA – large for 
gestational age, US – ultrasound, Wgt – weight, w – weeks. 
a post hoc test assessing BMI obese as binary. 
b Median (IQR) shown and Mann-Whitney test used.  
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Table 2. Pregnancy outcomes in pregnancies of large for gestational age infants with and without 
neonatal morbidity. 
  LGA no morbidity LGA and morbidity   
 
(n=433; 88%) (n=58; 12%) 
 
  Mean ±SD or n (%) Mean ± SD or n (%) p value 
Preeclampsia 19 (4.4) 4 (6.9) 0.40 
Gestational Hypertension 32 (7.4) 4 (6.9) 0.89 
Gestational diabetes     
 
   No 271 (62.6) 40 (69.0) 
 
   Yes 16 (3.7) 5 (8.6) 0.07 
   Unknown 146 (33.7) 13 (22.4) 
 
Induction of labor 125 (28.9) 27 (46.6) 0.006 
Mode of delivery     
 
   Spontaneous Vaginal 121 (27.9) 10 (17.2) 
 
   Assisted Vaginal 112 (25.9) 20 (34.5) 0.21 
   Emergency c-section 132 (30.5) 21 (36.2) 
 
   Elective c-section 68 (15.7) 7 (12.1) 
 
Gestation at delivery 39.9 ±1.2 39.8 ±1.3 0.62 
Birthweight 4183 ±347 4300 ±440 0.02 
Birthweight centiles 
a
 96 (93-98) 96 (93-99) 0.24 
a Median (IQR) shown and Mann-Whitney test used. 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Table 3. Risk factors for neonatal morbidity in large for gestational age infants.  
  Univariate Multivariable a 
  OR  95% CI OR  95% CI 
   Obesity (BMI >30 kg/m2) 2.38  1.22 - 4.65 1.11  0.51 - 2.41 
   No regular physical activity 20w 4.26  2.00 - 9.04 3.93  1.75 - 8.83 
   Rand glucose 20w (mmol/L) 1.57  1.23 - 2.00 1.52  1.17 - 1.97 
   US HC/AC ratio b 1.34  1.02 - 1.75 1.24  0.93 - 1.67 
Abbreviations: AC – abdominal circumference, BMI – body mass index, HC – head circumference, US – 
ultrasound, w – weeks.  
a Adjusted for all factors listed in addition to birthweight, GA at delivery and GDM. 
b HC/AC ratio was inversed and standardized (unit of one standard deviation)  
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